Heart News and Research

RSS

Blocking a naturally occurring molecule reverses deadly lung disease in preclinical models

Researchers blocked a naturally occurring molecule to reverse pulmonary arterial hypertension in preclinical models, a finding that could point to a new treatment approach for people with a rare and often fatal lung disease.

2 Sep 2026

Post-trauma mental health conditions increase future cardiovascular risks

Mental health conditions, such as posttraumatic stress disorder (PTSD), substance abuse, depression and anxiety, can develop after people experience trauma.

2 Sep 2026

Scientists develop lab-grown heart tissue model for heart failure

Scientists study the underlying causes of a disease or test new potential drugs in animal models or cells obtained from human biopsy specimens before clinical trials.

2 Sep 2026

Plant-based fats improve long-term survival for prostate cancer patients

Men diagnosed with nonmetastatic prostate cancer can generally expect to live for many years after their diagnosis. However, cardiovascular disease and other cancers remain important threats to their long-term health.

2 Sep 2026

Bacterial protein fragment corisin found to drive pulmonary fibrosis

A bacterial protein fragment called corisin drives the process of pulmonary fibrosis by infiltrating and disrupting the cell's quality-control system, researchers at the University of Illinois Urbana-Champaign and Mie University in Japan found in a new study.

2 Sep 2026

Stay sharp after menopause: How aerobic exercise can improve key thinking skills

Regular aerobic exercise – the kind that gets your heart pumping – can improve important thinking skills called executive functions, and the benefits appear especially strong for women after menopause, according to Rutgers researchers.

2 Sep 2026

Muscle matters: Simple scan could predict heart surgery risks

Around one in four heart surgery patients develop serious lung complications – but a new Adelaide-led study is testing a simple bedside scan that could predict who is most at risk before symptoms appear.

2 Sep 2026

ECG-CLIP improves heart disease detection using less labeled data

Clinicians often use a medical test called a 12-lead electrocardiogram (ECG) to diagnose heart problems, which uses electrodes placed on the chest and limbs to record the heart's electrical activity.

1 Sep 2026

Mizzou researchers explore first drug treatment for aortic valve calcification

University of Missouri researchers are advancing a promising new approach to treating a serious heart condition that affects millions of older adults worldwide.

1 Sep 2026

Smartwatches may overestimate calories burned during exercise

Smartwatches can significantly overestimate how many calories people burn during exercise, and their calorie estimates become less accurate as body fat increases, according to a new Florida International University study.

1 Sep 2026

Study uncovers cause of abnormal breathing in Rett syndrome

Hyperventilating. Breath holding until they turn blue. This abnormal breathing is frequent and disturbing in people with Rett syndrome, a rare genetic disease.

1 Sep 2026

Certain diabetes patients face higher ketoacidosis risk with SGLT2 drugs

Patients with type 2 diabetes who have high blood glucose levels, low body weight, or a history of ketoacidosis are at increased risk of developing this serious condition when treated with so-called SGLT2 inhibitors.

1 Sep 2026

NIH grant funds research on environmental triggers for sickle cell disease

The Icahn School of Medicine at Mount Sinai has received a $4.1 million grant from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, to study how everyday exposures affect the health of people with sickle cell disease.

1 Sep 2026

Blocking a key protein protects against metabolic liver damage

Obesity-related metabolic liver disease affects hundreds of millions of people worldwide, but only some fraction of those livers develop scarring, become inflamed, and eventually fail. University of Utah researchers have identified a protein, EFHD1, that appears to drive that transition by triggering an out-of-place antiviral immune response.

1 Sep 2026

New scLS algorithm advances gene expression trajectory analysis

Single-cell RNA sequencing (scRNA-seq) is a method to measure gene expression of individual cells, allowing observation of various cellular processes, including cell differentiation, the cell cycle, and stimulus-response for each unique cell instead of averaging across millions of cells.

1 Sep 2026

Antiviral COVID-19 drug shows no benefit for Long COVID

Results from a clinical trial funded by the National Institutes of Health (NIH) and published today in the journal Lancet Infectious Diseases show that the antiviral drug, PAXLOVID, commonly prescribed to treat acute COVID-19, does not have an impact on Long COVID symptoms when compared to placebo.

1 Sep 2026

Aerobic exercise boosts executive function in postmenopausal women

31 Aug 2026

Semaglutide did more than cut weight in this analysis of 6,239 adults

A systematic review and meta-analysis of nine randomized controlled trials involving 6,239 adults with overweight or obesity without diabetes found that subcutaneous semaglutide produced substantially greater reductions in body weight, waist circumference, and C-reactive protein than placebo. The higher dose of 7.2 mg semaglutide showed potential for greater weight loss, although the evidence is largely based on a single trial and requires confirmation.

31 Aug 2026

Social media messages could empower parents to prevent teen vaping

Parents are an important line of defense against teen vaping, yet many lack the knowledge and tools needed to recognize vaping products, understand their risks and prevent their children from using them.

31 Aug 2026

CAC-based statin initiation shows no difference in major cardiovascular events

There was no difference in major cardiovascular events when statin initiation was based on coronary artery calcium compared with traditional risk factor assessment, according to results presented in a Hot Line session today at ESC Congress 2026.

31 Aug 2026